These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 37011767)
1. Design, synthesis and biological evaluation of quinazoline SOS1 inhibitors. Jiang H; Fan Y; Wang X; Wang J; Yang H; Fan W; Tang C Bioorg Med Chem Lett; 2023 May; 88():129265. PubMed ID: 37011767 [TBL] [Abstract][Full Text] [Related]
2. Development of Son of Sevenless Homologue 1 (SOS1) Modulators To Treat Cancers by Regulating RAS Signaling. Luo G; Wang B; Hou Q; Wu X J Med Chem; 2023 Apr; 66(7):4324-4341. PubMed ID: 36987571 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of Son of Sevenless Homologue 1 (SOS1): Promising therapeutic treatment for KRAS-mutant cancers. Chen T; Tang X; Wang Z; Feng F; Xu C; Zhao Q; Wu Y; Sun H; Chen Y Eur J Med Chem; 2023 Dec; 261():115828. PubMed ID: 37778239 [TBL] [Abstract][Full Text] [Related]
4. Current advances and development strategies of targeting son of sevenless 1 (SOS1) in drug discovery. Wu J; Li X; Wu C; Wang Y; Zhang J Eur J Med Chem; 2024 Mar; 268():116282. PubMed ID: 38430853 [TBL] [Abstract][Full Text] [Related]
5. Discovery and Structure-Based Optimization of Benzimidazole-Derived Activators of SOS1-Mediated Nucleotide Exchange on RAS. Hodges TR; Abbott JR; Little AJ; Sarkar D; Salovich JM; Howes JE; Akan DT; Sai J; Arnold AL; Browning C; Burns MC; Sobolik T; Sun Q; Beesetty Y; Coker JA; Scharn D; Stadtmueller H; Rossanese OW; Phan J; Waterson AG; McConnell DB; Fesik SW J Med Chem; 2018 Oct; 61(19):8875-8894. PubMed ID: 30205005 [TBL] [Abstract][Full Text] [Related]
6. Discovery of Quinazolines That Activate SOS1-Mediated Nucleotide Exchange on RAS. Abbott JR; Patel PA; Howes JE; Akan DT; Kennedy JP; Burns MC; Browning CF; Sun Q; Rossanese OW; Phan J; Waterson AG; Fesik SW ACS Med Chem Lett; 2018 Sep; 9(9):941-946. PubMed ID: 30258545 [TBL] [Abstract][Full Text] [Related]
7. Nanobody Loop Mimetics Enhance Son of Sevenless 1-Catalyzed Nucleotide Exchange on RAS. Van Holsbeeck K; Fischer B; Gonzalez S; Gadais C; Versées W; Martins JC; Martin C; Wohlkönig A; Steyaert J; Ballet S Angew Chem Int Ed Engl; 2023 Jun; 62(24):e202219095. PubMed ID: 37067463 [TBL] [Abstract][Full Text] [Related]
8. Basis for signaling specificity difference between Sos and Ras-GRF guanine nucleotide exchange factors. Tian X; Feig LA J Biol Chem; 2001 Dec; 276(50):47248-56. PubMed ID: 11560935 [TBL] [Abstract][Full Text] [Related]
9. Deconstructing Ras signaling in the thymus. Kortum RL; Sommers CL; Pinski JM; Alexander CP; Merrill RK; Li W; Love PE; Samelson LE Mol Cell Biol; 2012 Jul; 32(14):2748-59. PubMed ID: 22586275 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis. Gerboth S; Frittoli E; Palamidessi A; Baltanas FC; Salek M; Rappsilber J; Giuliani C; Troglio F; Rolland Y; Pruneri G; Kreutmair S; Pallavicini I; Zobel M; Cinquanta M; Minucci S; Gomez C; Santos E; Illert AL; Scita G Leukemia; 2018 Mar; 32(3):820-827. PubMed ID: 28819285 [TBL] [Abstract][Full Text] [Related]
11. Discovery of Orally Bioavailable SOS1 Inhibitors for Suppressing KRAS-Driven Carcinoma. He H; Zhang Y; Xu J; Li Y; Fang H; Liu Y; Zhang S J Med Chem; 2022 Oct; 65(19):13158-13171. PubMed ID: 36173339 [TBL] [Abstract][Full Text] [Related]
12. SOS1, ARHGEF1, and DOCK2 rho-GEFs Mediate JAK-Dependent LFA-1 Activation by Chemokines. Toffali L; Montresor A; Mirenda M; Scita G; Laudanna C J Immunol; 2017 Jan; 198(2):708-717. PubMed ID: 27986909 [TBL] [Abstract][Full Text] [Related]
13. Blockade of mitogen-activated protein kinase cascade signaling in interleukin 6-independent multiple myeloma cells. Ogata A; Chauhan D; Urashima M; Teoh G; Treon SP; Anderson KC Clin Cancer Res; 1997 Jun; 3(6):1017-22. PubMed ID: 9815779 [TBL] [Abstract][Full Text] [Related]
15. Targeted Sos1 deletion reveals its critical role in early T-cell development. Kortum RL; Sommers CL; Alexander CP; Pinski JM; Li W; Grinberg A; Lee J; Love PE; Samelson LE Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12407-12. PubMed ID: 21746917 [TBL] [Abstract][Full Text] [Related]
16. CIIA functions as a molecular switch for the Rac1-specific GEF activity of SOS1. Hwang HS; Hwang SG; Cho JH; Chae JS; Yoon KW; Cho SG; Choi EJ J Cell Biol; 2011 Oct; 195(3):377-86. PubMed ID: 22042618 [TBL] [Abstract][Full Text] [Related]
17. The ability of Sos1 to oligomerize the adaptor protein LAT is separable from its guanine nucleotide exchange activity in vivo. Kortum RL; Balagopalan L; Alexander CP; Garcia J; Pinski JM; Merrill RK; Nguyen PH; Li W; Agarwal I; Akpan IO; Sommers CL; Samelson LE Sci Signal; 2013 Nov; 6(301):ra99. PubMed ID: 24222714 [TBL] [Abstract][Full Text] [Related]
18. Targeting Son of Sevenless 1: The pacemaker of KRAS. Kessler D; Gerlach D; Kraut N; McConnell DB Curr Opin Chem Biol; 2021 Jun; 62():109-118. PubMed ID: 33848766 [TBL] [Abstract][Full Text] [Related]
19. Requirement for Ras guanine nucleotide releasing protein 3 in coupling phospholipase C-gamma2 to Ras in B cell receptor signaling. Oh-hora M; Johmura S; Hashimoto A; Hikida M; Kurosaki T J Exp Med; 2003 Dec; 198(12):1841-51. PubMed ID: 14676298 [TBL] [Abstract][Full Text] [Related]
20. Small molecule Son of Sevenless 1 (SOS1) inhibitors: a review of the patent literature. Thompson SK; Buckl A; Dossetter AG; Griffen E; Gill A Expert Opin Ther Pat; 2021 Dec; 31(12):1189-1204. PubMed ID: 34253125 [No Abstract] [Full Text] [Related] [Next] [New Search]